Mutations in GBA have been identified as a genetic risk factor for Parkinson’s disease (38, 39), and mice that are heterozygous for the D409V GBA mutation recapitulate glycosphingolipid phenotypes of GBA-related Parkinson’s disease (40, 41). This evidence concerns the gene GBA1 and Parkinson disease.